| 1 | Study | 1.2% | |
| 2 | Report | 1.2% | |
| 3 | Case | 1.2% | |
| 4 | Medicina | 0.96% | |
| 5 | New | 0.72% | |
| 6 | Syndrome | 0.72% | |
| 7 | Risk | 0.48% | |
| 8 | Association | 0.48% | |
| 9 | Reconstruction | 0.48% | |
| 10 | Australia | 0.48% | |
| 11 | Patients | 0.48% | |
| 12 | Expert | 0.48% | |
| 13 | Toxic | 0.48% | |
| 14 | Dysfunction | 0.48% | |
| 15 | COVID-19 | 0.48% | |
| 16 | Postoperative | 0.48% | |
| 17 | Primary | 0.48% | |
| 18 | Lower | 0.48% | |
| 19 | Line | 0.48% | |
| 20 | Research | 0.48% | |
| 21 | Gene | 0.48% | |
| 22 | FDA | 0.48% | |
| 23 | Delhi | 0.48% | |
| 24 | Undergoing | 0.48% | |
| 25 | Retrospective | 0.48% | |
| 26 | Covid | 0.48% | |
| 27 | 3D | 0.24% | |
| 28 | IMCRJ | 0.24% | |
| 29 | Mondiale. | 0.24% | |
| 30 | Prime | 0.24% | |
| 31 | Reduced | 0.24% | |
| 32 | Urine | 0.24% | |
| 33 | Center | 0.24% | |
| 34 | Rangel | 0.24% | |
| 35 | Ultrasonic | 0.24% | |
| 36 | Free | 0.24% | |
| 37 | Revision | 0.24% | |
| 38 | Hyperreactivity | 0.24% | |
| 39 | Consistent | 0.24% | |
| 40 | Chuvi | 0.24% | |
| 41 | Agonist-Associated | 0.24% | |
| 42 | Gyroscopic | 0.24% | |
| 43 | K-CONNECT | 0.24% | |
| 44 | Device | 0.24% | |
| 45 | Jai | 0.24% | |
| 46 | Chuac | 0.24% | |
| 47 | ≪Agire | 0.24% | |
| 48 | R$ | 0.24% | |
| 49 | Analyzing | 0.24% | |
| 50 | Makhija | 0.24% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||